Adaptive Radiotherapy Using Helical Tomotherapy for Head and Neck Cancer in Definitive and Postoperative Settings: Initial Results

Clinical Oncology

Volumn 24, Issue 3, 2012, Pages 208-215

  Capelle, L ^a   Mackenzie, M ^a   Field, C ^a   Parliament, M ^a   Ghosh, S ^a   Scrimger, R ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

Adaptive radiotherapy; Head and neck cancer; Radiotherapy planning; Tomotherapy; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; NASOPHARYNX CARCINOMA; PAROTID GLAND CANCER; PAROTID GLAND CARCINOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SKIN CARCINOMA; SPINAL CORD; SPINAL CORD CANCER; SQUAMOUS CELL CARCINOMA; TOMOTHERAPY; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; WEIGHT LOSS;

EID: 84857921366     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.11.005     Document Type: Article

References (21)

1. Vergeer M.R., Doornaert P.A.H., Rietveld D.H.F., et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009, 74:1-8.
2. Hansen E.K., Bucci M.K., Quivey J.M., et al. Repeat CT imaging and replanning during the course of IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 2006, 64:355-362.
3. Wang W., Yang H., Hu W., et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2010, 77:617-621.
4. Wu Q., Chi Y., Chen P.Y., et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009, 75:924-932.
5. Blanco A.I., Chao C., El Naqa I., et al. Dose-volume modeling of the salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:1055-1069.
6. Eisbruch A., Haken R.K.T., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999, 45:577-587.
7. Münter M.W., Karger C.P., Hoffner S.G., et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 2004, 58:175-184.
8. Archambeau J.O., Pezner R., Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995, 31:1171-1185.
9. International Commission on Radiation Units and Measurements (ICRU) Report No. 62, Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50), vol. 62 1999, ICRU, Bethesda MD.
10. Mannarini L., Kratochvil V., Calbrese L., et al. Human papilloma virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital 2009, 29:119-126.
11. Bhide S.A., Davies M., Burke K., et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys 2010, 76:1360-1368.
12. Han C., Chen Y.J., Liu A., et al. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:1256-1262.
13. Vàsquez Osorio E.M., Hoogeman M.S., Al-Mamgani A., et al. Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys 2008, 70:875-882.
14. Castadot P., Lee J.A., Geets X., et al. Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol 2010, 20:84-93.
15. Loo H., Fairfoul J., Chakrabati J.C., et al. Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treat on the tomotherapy HiArt™ system. Clin Oncol 2011, 23:40-47.
16. Lee C., Langen K.M., Lu W., et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys 2008, 71:1563-1571.
17. Han C., Chen Y., Liu A., et al. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:1254-1262.
18. O'Daniel J.C., Garden A.S., Schwartz D.L., et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?. Int J Radiat Oncol Biol Phys 2007, 69:1290-1296.
19. Castadot P., Lee J.A., Parraga A., et al. Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment for head and neck tumors. Radiother Oncol 2008, 89:1-12.
20. Tsuji S.Y., Hwang A., Weinberg V., et al. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010, 77:707-714.
21. Schwartz DL, Dong L. Adaptive radiation therapy for head and neck cancer - can an old goal evolve into a new standard? J Oncol (in press).